![Kyle Haraldsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kyle Haraldsen
Keine laufenden Positionen mehr
Karriereverlauf von Kyle Haraldsen
Ehemalige bekannte Positionen von Kyle Haraldsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
SANA AB | Corporate Officer/Principal | 01.01.2021 | - |
Ausbildung von Kyle Haraldsen
Northeastern University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Dänemark | 2 |
Operativ
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SANA AB | Health Technology |
Private Unternehmen | 1 |
---|---|
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Kyle Haraldsen
- Erfahrung